PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced the expansion of its health and environmental focus to India with the opening of a new global EcoAnalytixTM application and technical center in Mumbai. The EcoAnalytix application and technical center will be dedicated to application development and methods optimization for a range of scientific and industrial laboratory applications, including environmental monitoring, food safety, and sustainable energy.
The opening of the EcoAnalytix application and technical center in Mumbai was marked earlier today by a celebration attended by employees, media and special guests. PerkinElmer global- and India-based executives, including PerkinElmerâ€™s president and chief executive officer, Robert F. Friel, joined attendees at The Intercontinental Hotel in South Mumbai for the event.
â€œWe are pleased with the progress we have made in India to date and feel that todayâ€™s announcement demonstrates our commitment to making significant and long-term investments in India and the Asia-Pacific region that support the expansion of the health and environmental infrastructures of emerging growth nations,â€ said Friel. â€œThe expansion of our global EcoAnalytix initiative to India helps ensure that our ecosystem and public health and safety are preserved now and for future generations.â€
India represents a key market for PerkinElmer, with significant growth opportunities in areas including, environmental monitoring, neonatal and maternal screening, and pharmaceutical research. PerkinElmer India currently employs approximately 170 people in Bangalore, Baroda, Chennai, Hyderabad, Kolkatta, Mumbai, New Delhi, Pune and Thane.
EcoAnalytix is PerkinElmerâ€™s collaborative problem-solving initiative that creates application-based solutions to improve business ecosystems, while supporting local, regional and global initiatives that contribute to a healthier ecosystem worldwide.
Factors Affecting Future Performance
This press release contains â€œforward-lookingâ€ statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as â€œbelieves,â€ â€œintends,â€ â€œanticipates,â€ â€œplans,â€ â€œexpects,â€ â€œprojects,â€ â€œforecasts,â€ â€œwillâ€ and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on managementâ€™s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) markets into which we sell our products decline or do not grow as anticipated; (4) our failure to protect adequately our intellectual property; (5) the loss of any of our licenses or licensed rights; (6) our ability to compete effectively; (7) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (8) disruptions in the supply of raw materials and supplies; (9) our ability to produce an adequate quantity of products to meet our customersâ€™ demands; (10) the manufacture and sale of products may expose us to product liability claims; (11) our failure to maintain compliance with applicable government regulations; (12) regulatory changes; (13) our failure to comply with health care industry regulations; (14) economic, political and other risks associated with foreign operations; (15) our ability to retain key personnel; (16) restrictions in our credit agreements; (17) our ability to realize the full value of our intangible assets; and (18) other factors which we describe under the caption â€œRisk Factorsâ€ in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.8 billion in 2007, has 9,100 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.
Michael A. Lawless, 781-663-5659
Stephanie Wasco, 781-663-5701